Recent genomic studies of head and neck squamous cell carcinoma by The Cancer Genome Atlas as well as other groups identified deletions or mutations in tumor necrosis factor receptor-associated factor 3 (TRAF3) and cylindromatosis lysine 63 deubiquitinase (CYLD) that previously were implicated in nuclear factor-κB (NF-κB) and antiviral interferon responses. In this issue, Hajek et al find genomic alterations in TRAF3/CYLD define distinct subsets of human papillomavirus-positive head and neck squamous cell carcinomas with associated activation of transcription factor NF-κB, episomal human papillomavirus infection of tumors, and improved patient survival. See also pages 000-000.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2lU7ubM
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου